Ibrance and Haloperidol decanoate drug interactions - a phase IV clinical study of FDA data
Summary:
We study 106,323 people who take Ibrance (palbociclib) and Haloperidol decanoate (haloperidol decanoate). There is no drug interaction reported.
The study analyzes what interactions people have when they take Ibrance and Haloperidol decanoate. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Ibrance?
Ibrance has active ingredients of palbociclib. eHealthMe is studying from 104,433 Ibrance users. Check the latest studies of Ibrance.
What is Haloperidol decanoate?
Haloperidol decanoate has active ingredients of haloperidol decanoate. eHealthMe is studying from 1,890 Haloperidol decanoate users. Check the latest studies of Haloperidol decanoate.
No report is found.
Do you take Ibrance and Haloperidol decanoate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ibrance (104,433 reports)
- Haloperidol decanoate (1,890 reports)
How the study uses the data?
The study uses data from the FDA. It is based on palbociclib and haloperidol decanoate (the active ingredients of Ibrance and Haloperidol decanoate, respectively), and Ibrance and Haloperidol decanoate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cetirizine Hydrochloride cause Chest Pain Aggravated? - 24 seconds ago
- Bipolar I Disorder and Fluid Retention - 58 seconds ago
- Could Aceon cause Enlarged Heart? - 59 seconds ago
- Perphenazine vs. Sertraline Hydrochloride, side effect and effectiveness comparison - a minute ago
- Could Hytrin cause Pleural Effusion? - a minute ago
- Could Glyburide cause Difficulty In Walking? - a minute ago
- Could Cardizem cause Urinary Retention? - a minute ago
- Drug interactions of Pepcid and Tarpeyo - a minute ago
- Drug interactions of Coumadin and Lactobacillus Acidophilus - a minute ago
- Drug interactions of Celebrex and Ibuprofen And Pseudoephedrine Hydrochloride - a minute ago